Dr. Gregg Fonarow serves as the director of the Ahmanson-UCLA Cardiomyopathy Center, co-chief of UCLA’s Division of Cardiology, and co-director of UCLA’s Preventative Cardiology Program. He is also ...

A session at the 68th American College of Cardiology Scientific Session continues the ongoing debate whether a CMS reimbursement model has contributed to rising mortality in patients with heart ...

Please provide your email address to receive an email when new articles are posted on . Elevated but “normal” blood glucose may be a target for cardiovascular disease risk reduction. Researchers ...

"Almost 75 percent of heart attack patients fell within recommended targets for LDL cholesterol, demonstrating that the current guidelines may not be low enough to cut heart attack risk in most who ...

Only a minority of patients are prescribed triple therapy and even fewer are prescribed quadruple therapy at the time of hospital discharge following a new diagnosis of heart failure with reduced ...

Fans may find it sad, but the fact is that Indie rock is fair game to academic cultural anthropologists like Fonarow, a former record company employee and now a lecturer at UCLA. Her study began at an ...

Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) has expanded dramatically in recent years, but getting patients on all four pillars remains a ...

Heart failure is often diagnosed after patients have already lost much of their function and quality of life, but emerging tools that noninvasively measure heart function may offer new ways to catch ...